Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of Multiple Doses of COR-001
Clinical trial NCT02868229 · COMPLETED
Trial details
- NCT number
- NCT02868229
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-12
- Primary completion
- 2018-12-11
- Enrollment
- 61
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.